Previous close | 2.5200 |
Open | 2.5000 |
Bid | 2.4400 x 0 |
Ask | 2.6800 x 0 |
Day's range | 2.5000 - 2.6200 |
52-week range | 1.6340 - 2.8550 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BOSTON, April 25, 2024--PureTech Announces Annual Results for Year Ended December 31, 2023
BOSTON, April 18, 2024--PureTech Health: Notice of Results
BOSTON, April 16, 2024--PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis